We are live on ! Find out more
FC

Fairscale Capital Portfolio holdings

AUM $167M
1-Year Est. Return 28.67%
This Fund
S&P 500
This Quarter Est. Return
+18.51%
1 Year Est. Return
+28.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$167M
AUM Growth
+$22.8M
Cap. Flow
+$1.04M
Cap. Flow %
0.62%
Top 10 Hldgs %
52.44%
Holding
444
New
7
Increased
24
Reduced
43
Closed
3

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$566K
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$297K
3
IJK icon
iShares S&P Mid-Cap 400 Growth ETF
IJK
+$297K
4
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$219K
5
CPSU
Calamos S&P 500 Structured Alt Protection ETF - June
CPSU
+$199K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$222K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$126K
3
NVDA icon
NVIDIA
NVDA
+$118K
4
FCX icon
Freeport-McMoran
FCX
+$107K
5
SNPS icon
Synopsys
SNPS
+$101K

Sector Composition

Rank Sector Weight
1 Miscellaneous 52.24%
2 Technology 20.89%
3 Financials 6.18%
4 Communication Services 6%
5 Consumer Discretionary 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYM icon
351
Symbotic
SYM
$5.58B
$4.54K ﹤0.01%
101
– –
CVS icon
352
CVS Health
CVS
$124B
$4.04K ﹤0.01%
39
– –
SNPS icon
353
Synopsys
SNPS
$75.5B
$4.01K ﹤0.01%
9
-214
-96% -$101K
INSM icon
354
Insmed
INSM
$27.6B
$3.94K ﹤0.01%
37
– –
VDE icon
355
Vanguard Energy ETF
VDE
$10.9B
$3.75K ﹤0.01%
25
– –
QUAL icon
356
iShares MSCI USA Quality Factor ETF
QUAL
$47.5B
$3.73K ﹤0.01%
17
– –
ISOU
357
IsoEnergy Ltd
ISOU
$731M
$3.73K ﹤0.01%
374
– –
CELH icon
358
Celsius Holdings
CELH
$7.76B
$3.72K ﹤0.01%
127
– –
SWKS icon
359
Skyworks Solutions
SWKS
$11.1B
$3.66K ﹤0.01%
54
– –
MRP
360
Millrose Properties Inc
MRP
$5.32B
$3.64K ﹤0.01%
121
– –
MICC
361
The Magnum Ice Cream Company N.V.
MICC
$11.8B
$3.62K ﹤0.01%
208
– –
CVNA icon
362
Carvana
CVNA
$53.7B
$3.62K ﹤0.01%
55
– –
OMC icon
363
Omnicom Group
OMC
$22.7B
$3.61K ﹤0.01%
49
– –
IEMG icon
364
iShares Core MSCI Emerging Markets ETF
IEMG
$165B
$3.48K ﹤0.01%
42
– –
FPH icon
365
Five Point Holdings
FPH
$371M
$3.27K ﹤0.01%
621
– –
EW icon
366
Edwards Lifesciences
EW
$51.8B
$3.26K ﹤0.01%
36
– –
CE icon
367
Celanese
CE
$4.9B
$3.22K ﹤0.01%
70
– –
CRSP icon
368
CRISPR Therapeutics
CRSP
$5.39B
$3.22K ﹤0.01%
59
– –
ITRI icon
369
Itron
ITRI
$4.25B
$3.2K ﹤0.01%
37
– –
PYPL icon
370
PayPal
PYPL
$47B
$3.15K ﹤0.01%
73
– –
BUZZ icon
371
VanEck Social Sentiment ETF
BUZZ
$99.6M
$3.07K ﹤0.01%
83
– –
GDRX icon
372
GoodRx Holdings
GDRX
$1.19B
$3.05K ﹤0.01%
1,060
– –
LAC
373
Lithium Americas
LAC
$1.09B
$3.05K ﹤0.01%
792
– –
ECL icon
374
Ecolab
ECL
$78.3B
$2.79K ﹤0.01%
10
– –
ELV icon
375
Elevance Health
ELV
$88.4B
$2.71K ﹤0.01%
7
– –
13 14
15
16 17

Similar funds

MWS
MFA Wealth Services Thousand Oaks, California $167M AUM 20.54% 1-Year Est. Return
IVGAI
Index Venture Growth Associates IV St. Helier, Jersey $167M AUM 58.25% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $167M AUM 4.07% 1-Year Est. Return
BV
Boxwood Ventures Chicago, Illinois $168M AUM 33.01% 1-Year Est. Return
EPI
Eddie Patel Inc Chicago, Illinois $167M AUM
GWA
Genesis Wealth Advisors Braintree, Massachusetts $167M AUM 17.82% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
E
Evansbrook Bolingbrook, Illinois $168M AUM

Fairscale Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Fairscale Capital held 444 positions worth $167M, up 16% from $145M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 2.3%. Fairscale Capital opened 7 new positions and exited 3, leaving the 444-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 51% a quarter earlier, followed by Technology and Financials.

  • Fairscale Capital's largest Q2 2026 buy was Calamos S&P 500 Structured Alt Protection ETF - June: 7,230 shares worth $200K.
  • Fairscale Capital added most to Invesco QQQ Trust in Q2 2026, an estimated $566K increase.
  • Fairscale Capital's biggest Q2 2026 reduction was Amgen, cutting an estimated $222K.
  • Fairscale Capital fully exited Hologic in Q2 2026, selling an estimated $34.2K.
  • Fairscale Capital's ten largest holdings make up 52% of its $167M portfolio in Q2 2026.
  • Fairscale Capital opened 7 new positions and closed 3 in Q2 2026.
  • Fairscale Capital's portfolio value rose 16% quarter-over-quarter to $167M.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.